Vyvgart (efgartigimod alfa)

pCPA File Number: 22530

Negotiation Status:

Under consideration for negotiation

Indication(s):

Generalized myasthenia gravis (gMG)

Sponsor/Manufacturer:

Argenx Canada Inc.

CADTH Project Number:

SR0782-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable